Final Chance to Save! Register by February 3 and Save up to $200!
The manufacturing environment within our industry is changing rapidly in response to new products with increasing complexity, evolving regulatory expectations, changing technologies, and a need to improve our manufacturing performance.
Gain the newest and most comprehensive information about traditional and biopharmaceutical science, manufacturing technology, quality and evolving regulations from leading subject matter experts at PDA’s premier event, the 2015 PDA Annual Meeting. Leading the discussions:
• Jeff Boyd, Head of Technical Operations & Gene Therapies Unit, Novartis
• Michael O’Brien, Head, Pharmaceutical Sciences, Pfizer Inc.
• Jeff Levy, Vice President, Technical Services, Manufacturing Science,
Eli Lilly & Company
The 2015 PDA Annual Meeting is the only event that gives you a view into the future, enabling you and your company to prepare today for the industry of tomorrow.
Want to learn more? From March 19-20, five in-depth education courses will be held. These courses will teach you about:
• Technical and Regulatory Challenges of Combination Drug Delivery
Products – Pre-filled Syringes, Autoinjectors and Injection Pens (March 19)
• NEW COURSE The Quality Culture and Its Measurement (March 19)
• NEW COURSE Applying Six Sigma Techniques to the Process Validation
Lifecycle (March 19)
For more information and to register, please visit
pdaannualmeeting.org Join the conversation at #PDAAnnual
The Parenteral Drug Association presents... 2015 PDA Annual Meeting
March 16-18, 2015 Red Rock Casino Resort and Spa, Las Vegas, NV
Exhibition: March 16-17 Post-Conference Workshop: March 18-19 Courses: March 19-20
Manufacturing Innovation and Efficiency: Achieving Quality Performance in Sterile and Biopharmaceutical Operations
• Sterile Pharmaceutical Dosage Forms: Basic Principles (March 19-20)
• Developing a Robust Supplier Management Process (March 20)
• Thomas Pizzuto, Vice President, Johnson and Johnson
• Mark McCamish, Global Head, Biopharmaceutical Development,
Sandoz International GmbH
• Sumant Ramachandra, MD, PhD, MBA, Senior Vice President R&D,
Medical and Regulatory Affairs, Chief Scientific Officer, Hospira
• And many more!
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76